These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18844000)
1. [The effect of hepatitis B virus infection on the outcome of hematopoietic stem cell transplantation]. Du H; Wang M; Yang DL; Huang Y; Han MZ Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):387-91. PubMed ID: 18844000 [TBL] [Abstract][Full Text] [Related]
2. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408 [TBL] [Abstract][Full Text] [Related]
3. [The impact of hepatitis B virus infected patients or donors on the outcome of hematopoietic stem cell transplantation]. Feng S; Han M; Zhang L; Li C; Qiu L; Li H; Wang Z; Jiang R; Yan W; Han Z Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):414-6. PubMed ID: 11877014 [TBL] [Abstract][Full Text] [Related]
4. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
5. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia]. Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032 [TBL] [Abstract][Full Text] [Related]
6. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia]. Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation]. Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621 [TBL] [Abstract][Full Text] [Related]
8. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation]. Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659 [TBL] [Abstract][Full Text] [Related]
9. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942 [TBL] [Abstract][Full Text] [Related]
10. [Clinical study on acute kidney injury after myeloablative allogeneic hematopoietic cell transplantation]. Bao YS; Jiang EL; Wang M; Huang Y; Wei JL; Yang DL; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):401-4. PubMed ID: 19031744 [TBL] [Abstract][Full Text] [Related]
11. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection. Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110 [TBL] [Abstract][Full Text] [Related]
12. [A clinical study of allo-hematopoietic stem cell transplantation in HBsAg positive leukemia]. Chen Y; Xu LP; Liu KY; Liu DH; Han W; Chen H; Zhang YC; Chen YH; Huang XJ Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):316-9. PubMed ID: 18843958 [TBL] [Abstract][Full Text] [Related]
13. [A comparison of clinical outcomes between unrelated donor and HLA-haploidentical donor hematopoietic stem cell transplantation]. Chen F; Wu DP; Sun AN; Ma X; Tang XW; Qiu HY; Miao M; Fu ZZ; Jin ZM; Wang Y; Wu XJ; Chen SN; He GS; Wang XL; Xue SL; Zhao Y; Chang WR Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):83-6. PubMed ID: 18681306 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia]. Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients. Liao YP; Jiang JL; Zou WY; Xu DR; Li J World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A; Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931 [TBL] [Abstract][Full Text] [Related]
19. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy. Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257 [TBL] [Abstract][Full Text] [Related]
20. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Onozawa M; Hashino S; Darmanin S; Okada K; Morita R; Takahata M; Shigematsu A; Kahata K; Kondo T; Tanaka J; Imamura M; Asaka M Biol Blood Marrow Transplant; 2008 Nov; 14(11):1226-30. PubMed ID: 18940676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]